CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 215 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,362,250 | +22.4% | 50,000 | 0.0% | 1.16% | +39.0% |
| Q2 2023 | $1,112,500 | +102623.9% | 50,000 | 0.0% | 0.83% | -1.7% |
| Q1 2023 | $1,083 | +6.6% | 50,000 | 0.0% | 0.85% | +18.1% |
| Q4 2022 | $1,016 | -99.9% | 50,000 | 0.0% | 0.72% | -20.5% |
| Q3 2022 | $1,282,000 | +7.8% | 50,000 | 0.0% | 0.90% | +4.4% |
| Q2 2022 | $1,189,000 | +5.6% | 50,000 | 0.0% | 0.86% | +6.7% |
| Q1 2022 | $1,126,000 | +13.7% | 50,000 | 0.0% | 0.81% | +27.1% |
| Q4 2021 | $990,000 | +0.6% | 50,000 | 0.0% | 0.64% | -4.8% |
| Q3 2021 | $984,000 | -10.5% | 50,000 | 0.0% | 0.67% | +1.8% |
| Q2 2021 | $1,100,000 | -7.6% | 50,000 | 0.0% | 0.66% | -6.8% |
| Q1 2021 | $1,190,000 | -9.0% | 50,000 | 0.0% | 0.71% | -6.4% |
| Q4 2020 | $1,308,000 | -24.8% | 50,000 | -50.0% | 0.75% | +29.8% |
| Q3 2020 | $1,740,000 | +106.9% | 100,000 | +100.0% | 0.58% | +14.4% |
| Q2 2020 | $841,000 | +41.6% | 50,000 | 0.0% | 0.51% | -3.6% |
| Q1 2020 | $594,000 | -1.8% | 50,000 | 0.0% | 0.53% | +19.8% |
| Q4 2019 | $605,000 | -14.4% | 50,000 | 0.0% | 0.44% | -6.6% |
| Q3 2019 | $707,000 | +26.7% | 50,000 | 0.0% | 0.47% | +38.9% |
| Q2 2019 | $558,000 | -4.9% | 50,000 | 0.0% | 0.34% | -7.9% |
| Q1 2019 | $587,000 | -12.1% | 50,000 | 0.0% | 0.37% | -41.8% |
| Q4 2018 | $668,000 | -4.7% | 50,000 | 0.0% | 0.63% | +39.8% |
| Q3 2018 | $701,000 | -10.8% | 50,000 | 0.0% | 0.45% | -15.4% |
| Q2 2018 | $786,000 | -36.7% | 50,000 | -33.8% | 0.53% | -34.7% |
| Q1 2018 | $1,242,000 | -27.6% | 75,500 | -20.5% | 0.82% | -18.7% |
| Q4 2017 | $1,716,000 | -6.4% | 95,000 | 0.0% | 1.01% | +6.2% |
| Q3 2017 | $1,834,000 | +63.6% | 95,000 | 0.0% | 0.95% | +59.7% |
| Q2 2017 | $1,121,000 | +70.4% | 95,000 | +58.3% | 0.59% | +62.0% |
| Q1 2017 | $658,000 | +13.3% | 60,000 | -25.0% | 0.37% | +2.2% |
| Q4 2016 | $581,000 | +11.7% | 80,000 | 0.0% | 0.36% | +17.8% |
| Q3 2016 | $520,000 | +19.0% | 80,000 | 0.0% | 0.30% | -4.1% |
| Q2 2016 | $437,000 | +16.8% | 80,000 | 0.0% | 0.32% | +18.7% |
| Q1 2016 | $374,000 | -6.0% | 80,000 | 0.0% | 0.27% | +16.6% |
| Q4 2015 | $398,000 | – | 80,000 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,825,262 | $138,621 | 7.54% |
| Novo Holdings A/S | 3,377,768 | $68,602,468 | 4.28% |
| Parallel Advisors, LLC | 3,724,664 | $75,647,926 | 3.28% |
| TANAKA CAPITAL MANAGEMENT INC | 35,539 | $722 | 2.29% |
| Quantedge Capital Pte Ltd | 251,312 | $5,104,147 | 1.71% |
| S&T BANK/PA | 346,306 | $7,033 | 1.30% |
| Freshford Capital Management, LLC | 249,000 | $5,057,190 | 1.09% |
| Birchview Capital, LP | 50,000 | $1,016 | 0.72% |
| FAS Wealth Partners, Inc. | 306,276 | $6,220,466 | 0.70% |
| Bridge City Capital, LLC | 60,824 | $1,235 | 0.63% |